Roche Hldg AG GEN

RHO5 
(XETRA) 
 
247.45 <%= Resources.Global.txtUp %>
Updated 24/06/2019
Change % 0.67% Stock price increasing
Change 1.65 Stock price increasing
Volume 3,184
High 250.10
Low 247.45
Open 248.70
ISIN CH0012032048
Prev close 245.80
# of shares 702.56M
Market cap 173,849M EUR
Intraday

Market closed
Roche Hldg AG GEN
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  247.45 -1.0% Stock price decreasing 2.8% Stock price increasing 1.8% Stock price increasing 16.6% Stock price increasing 32.1% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 84.24 -0.1% Stock price decreasing 9.4% Stock price increasing 6.6% Stock price increasing 21.0% Stock price increasing 38.5% Stock price increasing 16.5% Stock price increasing
 
Bristol-Myers Squibb Company 45.77 -5.8% Stock price decreasing -2.2% Stock price decreasing -5.3% Stock price decreasing -8.5% Stock price decreasing -16.6% Stock price decreasing -11.9% Stock price decreasing
 
Eli Lilly and Company 115.36 0.1% Stock price increasing -1.2% Stock price decreasing -12.0% Stock price decreasing 3.8% Stock price increasing 35.5% Stock price increasing -0.3% Stock price decreasing
 
Merck & Company Inc (new) 85.24 -0.1% Stock price decreasing 5.0% Stock price increasing 2.8% Stock price increasing 15.2% Stock price increasing 38.7% Stock price increasing 11.6% Stock price increasing
 
Pfizer Inc 43.76 0.6% Stock price increasing 4.3% Stock price increasing 3.2% Stock price increasing 3.7% Stock price increasing 20.3% Stock price increasing 0.3% Stock price increasing
 
Astrazeneca PLC ORD SHS $0.25 6,442.00 -0.1% Stock price decreasing 5.8% Stock price increasing 0.5% Stock price increasing 8.1% Stock price increasing 23.7% Stock price increasing 9.7% Stock price increasing
 
Novartis NAM SF 0,50 82.01 0.9% Stock price increasing 5.7% Stock price increasing -2.4% Stock price decreasing 11.1% Stock price increasing 29.9% Stock price increasing 10.2% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,605.60 0.0% Stock price increasing 1.5% Stock price increasing 2.8% Stock price increasing 7.2% Stock price increasing 6.7% Stock price increasing 7.7% Stock price increasing
 
Sanofi 77.05 -1.1% Stock price decreasing 2.5% Stock price increasing -1.6% Stock price decreasing 3.8% Stock price increasing 11.4% Stock price increasing 1.8% Stock price increasing

Company profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Peers

Instruments Last Change  
Abbott Labor.. 84.24 -0.6% Stock price decreasing
Bristol-Myer.. 45.77 0.2% Stock price increasing
Eli Lilly an.. 115.36 -0.2% Stock price decreasing
Merck & Comp.. 85.24 -0.3% Stock price decreasing
Pfizer Inc 43.76 0.0% Stock price unchanged
Astrazeneca .. 6,442.00 0.1% Stock price increasing
Novartis NAM.. 82.01 0.7% Stock price increasing
Glaxosmithkl.. 1,605.60 0.8% Stock price increasing
Sanofi 77.05 -0.1% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 June 2019 06:08:35
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB1 - 2019-06-26 07:08:35 - 2019-06-26 06:08:35 - 1000 - Website: OKAY